Issue navigation
Volume 28, Issue 9, September 2021
Editorial
Editor comments: focus on heart failure and cardiomyopathies
European Journal of Preventive Cardiology, Volume 28, Issue 9, September 2021, Pages 917–920, https://doi.org/10.1093/eurjpc/zwab102
Invited Editorial
Structural heart disease, cardiac dysfunction and heart failure: the ambiguity of a definition
European Journal of Preventive Cardiology, Volume 28, Issue 9, September 2021, Pages 921–923, https://doi.org/10.1177/2047487320937135
Full Research Paper
Prevalence and determinants of the precursor stages of heart failure: results from the population-based STAAB cohort study
European Journal of Preventive Cardiology, Volume 28, Issue 9, September 2021, Pages 924–934, https://doi.org/10.1177/2047487320922636
Invited Editorial
The pre-HFpEF stage: a new entity that requires proper phenotyping for better management
European Journal of Preventive Cardiology, Volume 28, Issue 9, September 2021, Pages 935–936, https://doi.org/10.1177/2047487320902326
Full Research Paper
Integrating natriuretic peptides and diastolic dysfunction to predict adverse events in high-risk asymptomatic subjects
European Journal of Preventive Cardiology, Volume 28, Issue 9, September 2021, Pages 937–945, https://doi.org/10.1177/2047487319899618
Invited Editorial
Overweight and obesity: time to reconsider their role in heart failure
European Journal of Preventive Cardiology, Volume 28, Issue 9, September 2021, Pages 946–947, https://doi.org/10.1177/2047487320933738
Full Research Paper
Body mass index and outcomes in ischaemic versus non-ischaemic heart failure across the spectrum of ejection fraction
European Journal of Preventive Cardiology, Volume 28, Issue 9, September 2021, Pages 948–955, https://doi.org/10.1177/2047487320927610
Invited Editorial
Is it time to treat women differently in the world of heart failure?
European Journal of Preventive Cardiology, Volume 28, Issue 9, September 2021, Page 956, https://doi.org/10.1177/2047487320931318
Full Research Papers
Impact of sex-specific target dose in chronic heart failure patients with reduced ejection fraction
European Journal of Preventive Cardiology, Volume 28, Issue 9, September 2021, Pages 957–965, https://doi.org/10.1177/2047487320923185
Sacubitril-valsartan versus enalapril for acute decompensated heart failure: a cost-effectiveness analysis
European Journal of Preventive Cardiology, Volume 28, Issue 9, September 2021, Pages 966–972, https://doi.org/10.1177/2047487319878953
Invited Editorial
Sodium glucose cotransporter 2 inhibitors for all HFrEF patients: can we afford it? A cost-effectiveness analysis of dapagliflozin
European Journal of Preventive Cardiology, Volume 28, Issue 9, September 2021, Pages 973–974, https://doi.org/10.1177/2047487320940103
Full Research Papers
Cost-effectiveness of dapagliflozin in chronic heart failure: an analysis from the Australian healthcare perspective
European Journal of Preventive Cardiology, Volume 28, Issue 9, September 2021, Pages 975–982, https://doi.org/10.1177/2047487320938272
Adverse events with sacubitril/valsartan in the real world: emerging signals to target preventive strategies from the FDA adverse event reporting system
European Journal of Preventive Cardiology, Volume 28, Issue 9, September 2021, Pages 983–989, https://doi.org/10.1177/2047487320915663
Temporal trends and predictors of inhospital death in patients hospitalised for heart failure in Germany
European Journal of Preventive Cardiology, Volume 28, Issue 9, September 2021, Pages 990–997, https://doi.org/10.1177/2047487320936020
Invited Editorial
Managing the complexities of cardiac amyloidosis: a path for success
European Journal of Preventive Cardiology, Volume 28, Issue 9, September 2021, Pages 998–999, https://doi.org/10.1177/2047487320928178
Review
Management of complications of cardiac amyloidosis: 10 questions and answers
European Journal of Preventive Cardiology, Volume 28, Issue 9, September 2021, Pages 1000–1005, https://doi.org/10.1177/2047487320920756
Invited Editorial
Are heart failure observational studies still useful? ‘No need to argue’*
European Journal of Preventive Cardiology, Volume 28, Issue 9, September 2021, Pages 1006–1008, https://doi.org/10.1177/2047487320932258
Full Research Paper
Rationale, design and baseline characteristics of the MyoVasc study: A prospective cohort study investigating development and progression of heart failure
European Journal of Preventive Cardiology, Volume 28, Issue 9, September 2021, Pages 1009–1018, https://doi.org/10.1177/2047487320926438
Invited Editorial
Sarcopenia in heart failure: ‘waste’ the appropriate time and resources, not the muscles
European Journal of Preventive Cardiology, Volume 28, Issue 9, September 2021, Pages 1019–1021, https://doi.org/10.1093/eurjpc/zwaa139
Full Research Paper
Impact of sarcopenia on prognosis in patients with heart failure with reduced and preserved ejection fraction
European Journal of Preventive Cardiology, Volume 28, Issue 9, September 2021, Pages 1022–1029, https://doi.org/10.1093/eurjpc/zwaa117
Letters to the Editor
The determinant effect of competing events in the analysis of heart failure incidence after myocardial infarction
European Journal of Preventive Cardiology, Volume 28, Issue 9, September 2021, Page e1, https://doi.org/10.1177/2047487320913183
The results are in: Cardiovascular benefits of glucagon-like peptide-1 receptor agonists – a trial sequential analysis
European Journal of Preventive Cardiology, Volume 28, Issue 9, September 2021, Pages e2–e5, https://doi.org/10.1177/2047487320918722
Predicting cardiovascular involvement in systemic sclerosis for a timely and better treatment approach
European Journal of Preventive Cardiology, Volume 28, Issue 9, September 2021, Pages e6–e7, https://doi.org/10.1177/2047487320932256
Research letters
Chemoreceptor hyperactivity in heart failure: Is lactate the culprit?
European Journal of Preventive Cardiology, Volume 28, Issue 9, September 2021, Pages e8–e10, https://doi.org/10.1177/2047487320915548
Personalized screening intervals for measurement of N-terminal pro-B-type natriuretic peptide improve efficiency of prognostication in patients with chronic heart failure
European Journal of Preventive Cardiology, Volume 28, Issue 9, September 2021, Pages e11–e14, https://doi.org/10.1177/2047487320922639
Obesity, overweight and survival in critically ill patients with SARS-CoV-2 pneumonia: is there an obesity paradox? Preliminary results from Italy
European Journal of Preventive Cardiology, Volume 28, Issue 9, September 2021, Pages e15–e17, https://doi.org/10.1177/2047487320939675
Novel prediction equation for appendicular skeletal muscle mass estimation in patients with heart failure: Potential application in daily clinical practice
European Journal of Preventive Cardiology, Volume 28, Issue 9, September 2021, Pages e18–e21, https://doi.org/10.1177/2047487320904236
Atrial fibrillation and obesity: Long-term incidence and outcomes after bariatric surgery
European Journal of Preventive Cardiology, Volume 28, Issue 9, September 2021, Pages e22–e24, https://doi.org/10.1177/2047487320904515
Glittre Activities Daily Living Test: Physiological responses in patients with heart failure
European Journal of Preventive Cardiology, Volume 28, Issue 9, September 2021, Pages e25–e27, https://doi.org/10.1177/2047487320911173
Circulating cell-free DNA levels are associated with adverse outcomes in heart failure: testing liquid biopsy in heart failure
European Journal of Preventive Cardiology, Volume 28, Issue 9, September 2021, Pages e28–e31, https://doi.org/10.1177/2047487320912375
Increased functional capacity after 12 weeks of exercise training does not transform into improved skeletal muscle metabolism or ultrastructure in heart failure patients on modern optimal medical therapy
European Journal of Preventive Cardiology, Volume 28, Issue 9, September 2021, Pages e32–e37, https://doi.org/10.1177/2047487320919863
Cardiovascular risk profile and events before and after treatment with anti-VEGF drugs in the setting of a structured cardio-oncologic program
European Journal of Preventive Cardiology, Volume 28, Issue 9, September 2021, Pages e38–e40, https://doi.org/10.1177/2047487320923056
The association between rotating night shift work and hypertension: A cross-sectional study among male workers
European Journal of Preventive Cardiology, Volume 28, Issue 9, September 2021, Pages e41–e44, https://doi.org/10.1177/2047487320906921
Invited Editorial
Assessing cardiovascular risk in cancer patients: opportunities and challenges
European Journal of Preventive Cardiology, Volume 28, Issue 9, September 2021, Pages e45–e46, https://doi.org/10.1177/2047487320943002
